Incidence of depression ‐ short‐term: < 6 months · adults with long‐term physical conditions (18 years or older)
It is very uncertain whether pharmacological interventions changes incidence of depression ‐ short‐term: < 6 months compared with placebo (very low certainty).
1 finding from 1 review
Incidence of depression ‐ medium term: 6‐12 months · adults with long‐term physical conditions (18 years or older)
It is very uncertain whether pharmacological interventions changes incidence of depression ‐ medium‐term: 6‐12 months compared with placebo (very low certainty).
1 finding from 1 review
Incidence of depression ‐ long‐term: >12 months · adults with long‐term physical conditions (18 years or older)
1 finding from 1 review
Tolerability ‐ total number of adverse events · adults with long‐term physical conditions (18 years or older)
1 finding from 1 review
Sleepiness during the night shift, postintervention; · Shift workers
4 findings from 1 review
no estimate extracted
2 studies · 184 participants
Very low
no estimate extracted
1 study · 16 participants
Low
no estimate extracted
1 study · 90 participants
Low
Show 1 more finding
Sleepiness during the night shift, postintervention; · Shift workers
1 finding from 1 review
Sleepiness during the night shift, postintervention; · Shift workers
5 findings from 1 review
Show 2 more findings
no estimate extracted
1 study · 7 participants
Very low
no estimate extracted
1 study · 9 participants
Very low
Quality of sleep · Shift workers
1 finding from 1 review
Self‐reported pain relief ‐ NPSI: ranges from 0 to 100. Higher scores are indicative of neuropathic pain. · adults and children with sickle cell disease experiencing neuropathic pain
1 finding from 1 review
Self‐reported pain relief ‐ S‐LANSS: Possible total scores range from 0 to 24, and a score of 12 or higher is indicative of neuropathic pain. · adults and children with sickle cell disease experiencing neuropathic pain
1 finding from 1 review
Patient Global Impression of Change · adults and children with sickle cell disease experiencing neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to improvement of symptoms · adults and children with sickle cell disease experiencing neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · adults and children with sickle cell disease experiencing neuropathic pain
1 finding from 1 review
Quality of sleep · adults and children with sickle cell disease experiencing neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment‐related adverse effects · adults and children with sickle cell disease experiencing neuropathic pain
It is very uncertain whether summary of findings ‐ Pharmacological intervention (pregabalin) changes treatment‐related adverse effects compared with placebo (very low certainty).
1 finding from 1 review
Fear of childbirth · women with fear of childbirth (tocophobia)
1 finding from 1 review
Caesarean section · women with fear of childbirth (tocophobia)
Non‐pharmacological interventions for fear of childbirth (tocophobia) probably leads to lower caesarean section compared with usual care (moderate certainty).
1 finding from 1 review
Anxiety ‐ not reported · women with fear of childbirth (tocophobia)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression · women with fear of childbirth (tocophobia)
1 finding from 1 review
Birth preferences: prefer caesarean section · women with fear of childbirth (tocophobia)
Non‐pharmacological interventions for fear of childbirth (tocophobia) showed no clear difference in birth preferences: prefer caesarean section compared with usual care (low certainty).
1 finding from 1 review